SUNPHARMA quarterly results and annual financials: sales, operating profit, OPM, net profit, EPS, balance sheet, cash flow and ratios like ROCE, with YoY and QoQ growth.
Sun Pharmaceutical Industries Ltd reported sales of ₹16,199 Cr, operating profit of ₹4,744 Cr (OPM 29%) and net profit of ₹1,995 Cr for the quarter ended Sep 2026. Figures in ₹ crore, consolidated where available.
SUNPHARMA quarterly results (₹ Cr)
Metric
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Sales
13,675
12,959
13,851
14,478
15,521
14,612
15,300
16,199
Expenses
9,666
9,243
9,550
9,951
10,572
10,658
10,882
11,455
Operating Profit
4,009
3,716
4,302
4,527
4,948
3,954
4,418
4,744
OPM
29%
29%
31%
31%
32%
27%
29%
29%
Other Income
149
251
-354
470
89
458
520
-752
Interest
52
49
75
100
78
86
100
75
Depreciation
631
664
701
730
732
775
739
758
Profit before tax
3,476
3,254
3,173
4,168
4,227
3,551
4,099
3,159
Tax
16%
34%
27%
25%
20%
23%
29%
37%
Net Profit
2,913
2,154
2,293
3,125
3,381
2,710
2,901
1,995
EPS in Rs
12.1
8.96
9.5
13
14.04
11.31
12.06
8.29
SUNPHARMA profit & loss, annual (₹ Cr)
Metric
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Mar 2026
TTM
Sales
38,654
43,886
48,497
52,578
58,462
61,631
Expenses
28,397
32,235
35,479
37,464
41,961
43,567
Operating Profit
10,258
11,650
13,018
15,114
16,501
18,064
OPM
27%
27%
27%
29%
28%
29%
Other Income
-3,505
459
865
1,444
1,895
316
Interest
127
172
238
231
339
339
Depreciation
2,144
2,529
2,557
2,575
2,938
3,005
Profit before tax
4,481
9,408
11,088
13,752
15,119
15,037
Tax
24%
9%
13%
20%
24%
-
Net Profit
3,389
8,513
9,610
10,965
11,509
10,987
EPS in Rs
13.64
35.32
39.91
45.55
47.84
45.7
Dividend Payout
73%
33%
34%
35%
33%
-
SUNPHARMA balance sheet (₹ Cr)
Metric
Mar 2024
Mar 2025
Sep 2025
Mar 2026
Sep 2026
Equity Capital
240
240
240
240
240
Reserves
63,427
71,978
77,580
83,330
89,040
Borrowings
3,274
2,362
5,215
4,627
3,241
Other Liabilities
18,387
17,328
20,672
20,210
22,317
Total Liabilities
85,328
91,908
1,03,706
1,08,407
1,14,838
Fixed Assets
23,248
22,586
33,371
32,822
35,110
CWIP
5,354
6,644
1,355
3,052
1,864
Investments
15,026
18,354
19,543
24,723
16,449
Other Assets
41,700
44,324
49,438
47,811
61,415
Total Assets
85,328
91,908
1,03,706
1,08,407
1,14,838
SUNPHARMA cash flows (₹ Cr)
Metric
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Mar 2026
Cash from Operating Activity
8,985
4,959
12,135
14,072
12,419
Cash from Investing Activity
-5,556
-7,220
-763
-5,183
-10,405
Cash from Financing Activity
-5,193
2,376
-6,710
-7,906
-2,513
Net Cash Flow
-1,765
115
4,662
983
-498
Free Cash Flow
7,550
2,895
9,964
12,005
8,906
CFO/OP
78%
56%
105%
96%
89%
CFO/EBITDAShare of operating profit converting into cash: CFO (before tax) / Operating Profit